ABCB1 is upregulated in acquisition of taxane resistance: Lessons from esophageal squamous cell carcinoma cell lines

Ruobing Wang, Anton Sumarpo, Yuriko Saiki, Na Chen, Makoto Sunamura, Akira Horii

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Esophageal cancer is one of the common malignancies worldwide, particularly in eastern African and Asian countries including Japan. Taxane (paclitaxel or docetaxel) is one of the effective chemotherapeutic reagents for patients with esophageal cancer, but acquisition of chemoresistance frequently occurs; this is one of the most frequent causes for therapeutic failure. In this study, we established three taxane resistant esophageal squamous cell carcinoma cell lines and explored possible mechanisms for the acquisition of chemoresistance. Microarray analyses indicated that the ABCB1 (ATP binding cassette subfamily B member 1) gene was significantly upregulated in taxane resistant esophageal cancer cell lines. Moreover, we found that siRNA mediated ABCB1 knockdown successfully restored drug sensitivity in both paclitaxel and docetaxel resistant esophageal cancer cell lines. In conclusion, we propose that ABCB1 might play a pivotal role in acquisition of taxane resistance and could be a promising target for treatment of patients with esophageal cancer after acquisition of taxane resistance.

Original languageEnglish
Pages (from-to)295-301
Number of pages7
JournalTohoku Journal of Experimental Medicine
Volume240
Issue number4
DOIs
Publication statusPublished - 2016 Dec

Keywords

  • ABCB1
  • Chemoresistance
  • Docetaxel
  • Esophageal squamous cell carcinoma
  • Paclitaxel

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'ABCB1 is upregulated in acquisition of taxane resistance: Lessons from esophageal squamous cell carcinoma cell lines'. Together they form a unique fingerprint.

  • Cite this